- Country: Japan
- Summary: a Set of Central Image Review Systems Involved in a Multicenter Phase Ii Clinical Trial Evaluating the Efficacy and Safety of Encorafenib + Binimetinib + Cetuximab Combination Therapy as Perioperative Chemotherapy for Patients with Distantly Meta...
- JPT Ref No: 127958747
- Deadline: 25 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- A set of central image review systems involved in a multicenter phase II clinical trial evaluating the efficacy and safety of encorafenib + binimetinib + cetuximab combination therapy as perioperative chemotherapy for patients with distantly metastatic resectable colorectal cancer harboring the BRAF V600E mutation.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINa Set of Central Image Review Systems Involved in a Multicenter Phase Ii Clinical Trial Evaluating the Efficacy and Safety of Encorafenib + Binimetinib + Cetuximab Combination Therapy as Perioperative Chemotherapy for Patients with Distantly Meta... - Japan Tender
The NATIONAL CANCER CENTER, a Government sector organization in Japan, has announced a new tender for a Set of Central Image Review Systems Involved in a Multicenter Phase Ii Clinical Trial Evaluating the Efficacy and Safety of Encorafenib + Binimetinib + Cetuximab Combination Therapy as Perioperative Chemotherapy for Patients with Distantly Meta.... This tender is published on JapanTenders under JPT Ref No: 127958747 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
